Sunday, December 3, 2023
Home 2023 April

Monthly Archives: April 2023

2023 Watch List

Adding Cardiol Therapeutics (CRDL) $0.59 to Watch List.

Editor / Curator -
Accelerator

Report: Expedia, Doordash, eCommerce Fashion Retailer and YouTube All Rolled Into...

Editor / Curator -
All News

Is Smart for Life (SMFL) $4.30, a Bargain Post Reverse Split?

Editor / Curator -
Psychedelic Stock Review

Is ATAI Live Sciences (ATAI) $2.00, Finally Turning?

Editor / Curator -
Psychedelic Stock Review

The Ketamine Endgame. Silo Pharmaceutical (SILO).

Editor / Curator -
Psychedelic Stock Review

The Ketamine Cure (NY Times)

Editor / Curator -
All News

A Good Bear Market, is a Terrible Thing to Waste. How...

Editor / Curator -
2023 Watch List

The Next Generation Of Mental Health Treatment: Psycheceutical Bioscience Inc.’s Novel...

Editor / Curator -
2022 Watch List

Ardelyx (ARDX) Resubmits New Drug Application to FDA.

Editor / Curator -
Psychedelic Stock Review

Psycheceutical Bioscience Inc.’s (BWVI) Novel Topical Ketamine Delivery.

Editor / Curator -
12Page 1 of 2

Latest article

Selling Under Cash. LQR House (LQR) Addresses Nasdaq Delisting.

All News Editor / Curator -
If You're a Sophisticated Speculator, and we do Mean Sophisticated, Study LQR House (LQR) or 'the Liquor House' Story.

LQR House (LQR). And the Numbers are In!

All News Editor / Curator -
A Situation Which Can't be Ignored! That's not to say run out and buy it, but this current valuation...

LQR Announces Proposed Reverse Split as Part of Nasdaq Compliance Plan

Internet News Editor / Curator -
LIVE QUOTE MIAMI BEACH, FL / ACCESSWIRE / November 21, 2023 / LQR House Inc....
The Internet Stock Review is one of Wall Streets oldest newsletters covering internet technology having launched in 1999. The Biotech Stock Review is rather old too, having launched in 2002. We make our money by purchasing stock with our services, so the better our client stocks do, the better we all do. And when we're wrong, we feel the pain too! See our research reports for important disclaimer details. Content is provided by Institutional Analyst Inc., the website is managed by Revelers.IO Media Group Inc. To see if your Company qualifies for coverage, call 310-594-8062
Contact us: [email protected]
© Managed by Revelers.IO Media Group Inc.